-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/topic-brief3-SUD.pdf
April 01, 2021 - settings, and inpatient settings.12-14 Chronic pain,
often defined as pain lasting longer than 3 to 6 months … , or past the time of normal tissue healing,
has an estimated prevalence of 20.4 percent in U.S. adults … In 2019, there were an estimated 20.4 million Americans 12 years or older with
past-year substance use … 6 months).15 In
people 85 years of age and older, the prevalence of chronic pain was 33.6 percent and … Outcomes were assessed at 12 months.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/mental-illness-outcomes_research-protocol.pdf
March 03, 2014 - Among adults with an SMI in 2008, less than 60 percent used any mental health services in the
past year … Criterion Inclusion Exclusion
Population § ≥ 18 years with SMI currently or at any time during the past … medical and psychiatric care)
§ Adverse effects of the use of QMs
Timeframes § Short term (≤ 6 months … ), intermediate term, and long term (≥12 months) § TBD
Setting § Inpatient or outpatient, primary … The dispositions of the peer review comments are documented and will be
published three months after
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/incident-user-design_research.pdf
May 01, 2012 - an intervention (most restrictive
design) to expanding enrollment to patients regardless of their past … in the US since 1980; consequently, apparent incident users during 1999 through 2001
may have had past … window to
define incident use, but based the classification on physicians’ self-reported recall of past … enrolled patients who had started either etanercept or infliximab therapy within the
previous six months … some propensity
scores predict a combination of incident drug use, persistence with a drug started months
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/abnormal-uterine-bleeding_research-protocol.pdf
November 21, 2011 - that is chronic in nature, meaning the
symptom has persisted for the majority of the prior three months … Nomenclature to classify symptomatic problem bleeding has evolved steadily over the
past several decades … Abnormal cyclic uterine bleeding: problem bleeding of three months or
greater duration, excluding … for three
months or longer. … Primary care management of abnormal uterine bleeding
*Problem bleeding for 3 months or longer,
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ear-infection_executive.pdf
May 01, 2013 - have OME; in particular, we sought
evidence specific to populations who have not been
examined in past … of less than
3 months. … TT improved hearing through
9 months after surgery compared with watchful waiting
(3–6 months: 8.8 … dB; 6–9 months: 4.2 dB) (high strength
of evidence); TT improved hearing by 10 dB at 4 to
6 months … Adenoidectomy was superior to no treatment for hearing
in one study at 6 months but not at 12 months
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/accountable-care-registries-guide-3rd-ed-addendum-white-paper-2018-5.pdf
January 01, 2018 - was within the Medicare minimum savings
rate, and decreased inpatient utilization in the first 21 months … Examples may include daily reports
on patients discharged from a hospital within the past week with … 6 months or patients with diabetes with an HbA1c of greater than nine who are not
taking insulin. … However, these data may not be available until several
months after the date of service, making them … six months or those discharged from acute care
within the past 30 days.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/angina-heart-attack-treatments_executive.pdf
January 01, 2014 - study (<3 months vs. 6 months vs … , 6 months vs. 12 months, and 6 months vs.
24 months); 1 observational study found no difference in … evidence due to imprecision: all RCTs (1 month vs. 6 months, 6 months
vs. 12 months, and 6 months vs … and 6 months vs.
24 months)
Stent thrombosis at 6 months, 1 year, and
2 years
SOE = Insufficient … leading cause of death in the United States
despite major advances in cardiovascular care over the past
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/febrile-infants-diagnosis-management_executive.pdf
March 01, 2012 - These criteria are comprised of clinical (appearance,
past medical history) and laboratory features … How do these findings vary by age within the age
range 0–3 months? … How do
these findings vary by age within the age range 0 to 3
months? … These studies included children with age range of
0–3 months. … Diagnosis and
Management of Febrile Infants (0–3 Months).
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/depression-postpartum-screening_research-protocol.pdf
May 01, 2013 - of postpartum
onset) will remain unchanged, although the window for diagnosis may be extended to 6 months … .2
Other diagnostic standards allow the definition of onset to extend beyond 4 weeks and up to
12 months … and general practitioners) should ask two questions to
identify possible depression:
• During the past … • During the past month, have you often been bothered by having
little interest or pleasure in doing … Maternal depressive symptoms at 2 to 4
months post partum and early parenting practices.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_executive.pdf
September 01, 2011 - • Oligoarthritis: Affects up to four joints
within the first 6 months of illness;
may be persistent … involving no
more than four joints) or extended
(i.e., involving more than four joints
after the first 6 months … 2
• Rheumatoid-factor positive (RF+) polyarthritis:
Affects five or more joints during the first 6
months … • Rheumatoid-factor negative (RF-) polyarthritis:
Affects five or more joints during the first 6
months … There is no cure for JIA, but over the past 25
years new therapies have provided great advances in
treatment
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-outcomes-chronic-kidney-rapid-research.pdf
November 01, 2024 - Background
In the past several years, there has been increasing appreciation for the interconnectedness … • Studies of minimum 3 months duration (it takes ~3
months for eGFR to stabilize)
None
Setting … • Cr (4 – 6 months) • No change
• BUN (n=3) (2 – 4
months)
• ↑
• CRP (n=3) • ↓ in all studies … evidence
• Alb (3 – 6 months) • insufficient
evidence
• Lipids (3 – 6
months)
• insufficient … (Figure 3), and that most of the studies show a followup time of 6 months.
-
effectivehealthcare.ahrq.gov/sites/default/files/s77.pdf
October 01, 2007 - Using past VA pharmacy utilization data, we esti-
mated the difference in pharmacy out-of-pocket expenditures … activity was expressed as the number of
prescriptions filled through the VA pharmacy during the prior 12
months … Models assumed
that prescription use from the prior 12 months would be
stable over the next year and
-
effectivehealthcare.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1406.pdf
June 01, 2014 - depending on expert comments received on interventions issued for
comment during the preceding 6 months … Healthcare Horizon Scanning System despite
extensive scanning since inception, and more recently (in the past … 15–18 months), even fewer topics
than previously have met criteria for tracking in the system.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-203-adhd-disposition-comments.pdf
January 01, 2018 - the authors’ responses to the comments are posted for
public viewing on the Web site approximately 3 months … TEP Reviewer #6 General Some questions HAVE been answered sufficiently in the past,
e.g. growth suppression … Did the authors mean "12 months or shorter?"
We now clarify that we meant 12-24
months.
51. … implications for clinical and
policy decision-making appears to be based on the entire
literature over the past … Please
see the citations in my comments above for key reviews of the
literature over the past 20 years
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/vaccine-safety_research-protocol.pdf
September 18, 2012 - adolescents (Table 1), adults (Table 2), and pregnant women (Table 3) has expanded
considerably over the past … – 6 years
Hepatitis A 12 months and older
http://www.effectivehealthcare.ahrq.gov/
Source: … HPV (human papillomavirus) 9 years – 26 years
Influenza (inactivated) 6 months and older
Influenza … ) 6 weeks – 18 years
Pneumococcal polysaccharide vaccine 2 years and older
Rotavirus 6 weeks – 8 months … Tdap (tetanus, diphtheria, and acellular
pertussis)
7 years and older
Varicella 12 months and
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/research-protocol-osteoporosis_2.pdf
October 05, 2018 - In short-term randomized controlled trials (RCTs) (18 months to 3 years),
bisphosphonates, denosumab … weekly 1-3 yr >3 yr
Bisphosphonate Zoledronic acid IV Annually 1-3 yr >3 yr
Biologic Denosumab SC 6 months … women
Participants with osteoporosis (osteoporosis defined as hip or vertebral DXA T-score ≤-2.5, past … account for
selection bias (adjust for age, comorbidity, and some measure of fracture risk [e.g., past … The disposition of comments will be published
three months after the publication of the evidence report
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/rapid-evidence-heart-disease.pdf
October 01, 2022 - It is not clear how these changes
may have affected the applicability of past studies to current practice … Over the past several decades, statins have consistently demonstrated
benefit in reduction of CV mortality … (mean range, 1.5 to 60
months). … Over a
median follow-up period of 41 months (interquartile range, 28 to 60 months), the addition of … )
12 months: MD 4.5 (95% CI 1.4–7.7)
24 months: MD 2.6 (95% CI -0.7–5.8)
Serious Adverse Event,
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antidepressants-update_research-protocol.pdf
July 13, 2011 - If a patient has responded to one agent in the past, is that agent better than
current pharmacologic … Good or fair quality, controlled observational studies
Minimum study duration
For all studies: 3 months … observational studies
Minimum study duration
For RCTs: 6 weeks
For observational studies: 3 months … Uncontrolled trials
Minimum study duration
For RCTs: 6 weeks
For observational studies: 3 months … the peer review comments are documented and will, for CERs
and Technical briefs, be published three months
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-outcomes-diabetes-rapid-research.pdf
November 01, 2024 - Background
In the past several years, there has been increasing appreciation for the interconnectedness … at 6 months, 0.29 at 12 months), or
other inflammatory markers. … at 6 months was lower than at 3 months. … )
• 6 months: −0.38% (95% CI
[−0.61, −0.16], p=0.0009)
3 months: 52%
6 months: 46%
• Differences … In addition, most studies have a follow-up time of
3 months and/or 6 months.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-ovarian-contraceptives_executive.pdf
June 01, 2013 - incidence (60 years and older).2
While advances in surgery, chemotherapy,
and radiation therapy over the past … The model was
run as a microsimulation, which allowed for conditioning
of probabilities based on past … :0.78
(0.54 to 1.15)
>60 months: 0.44
(0.29 to 0.65)
Mortality
Ever vs. never
use
2
(46,112 … Past use or duration of use did not appear to be related to
stroke risk, although we were unable to … in the general population,
5 months in BRCA2 carriers, and over a year in BRCA1
carriers, for users